Search results for "pancreatic"

showing 10 items of 545 documents

Inhibition of pro-inflammatory enzymes by inuviscolide, a sesquiterpene lactone from Inula viscosa

2006

Abstract This work concerns the pharmacological activity of inuviscolide, a sesquiterpenoid from Inula viscosa. It exerts inhibitory effects on elastase, cyclooxygenase 1 and secretory phospholipase A2. Furthermore, it reduces the skin leukocyte infiltration in a murine model of dermatitis induced by repeated application of 12-O-tetradecanoylphorbol 13-acetate.

DermatitisBiologyPharmacognosyPharmacologySesquiterpene lactoneSesquiterpeneLactonesMicechemistry.chemical_compoundDrug DiscoveryLeukocytesAnimalsHumansEnzyme InhibitorsPharmacologychemistry.chemical_classificationPancreatic Elastaseintegumentary systemPlant ExtractsAnti-Inflammatory Agents Non-SteroidalElastaseBiological activityGeneral MedicineEnzymechemistryBiochemistrybiology.proteinTetradecanoylphorbol AcetateInulaCyclooxygenaseSesquiterpenesLactonePhytotherapyFitoterapia
researchProduct

An unusual case of chronic diarrhea: a case report

2022

Gastroenteropancreatic-neuroendocrine neoplasms or tumors (GEP-NEN or NETs) are rare tumors arising from the diffuse neuroendocrine system. This clinical case highlights the complexity of the diagnostic process and the difficulties in interpreting the examinations for this type of tumor, showing how the negativity of firstlevel examinations did not prevent from performing further investigations, in the presence of a suggestive clinical presentation. The search of similar cases in the published literature suggests that this represents an unusual presentation of a NET.

DiarrheaSettore MED/09 - Medicina InternaPositron-Emission TomographyPositron Emission Tomography Computed TomographyEmergency MedicineInternal MedicineHumansOctreotide68Gallium-DOTATOC PET/CT Chromogranin A Diarrhea Gastroenteropancreatic-neuroendocrine tumor
researchProduct

SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance.

2021

Aim: Because mutations of splicing factor 3B subunit-1 (SF3B1) have been identified in 4% of pancreatic ductal adenocarcinoma (PDAC) patients, we investigated the activity of new potential inhibitors of SF3B1 in combination with gemcitabine, one of the standard drugs, in PDAC cell lines. Methods: One imidazo[2,1-b][1,3,4]thiadiazole derivative (IS1) and three indole derivatives (IS2, IS3 and IS4), selected by virtual screening from an in-house library, were evaluated by the sulforhodamine-B and wound healing assay for their cytotoxic and antimigratory activity in the PDAC cells SUIT-2, Hs766t and Panc05.04, the latter harbouring the SF3B1 mutations. The effects on the splicing pattern of pr…

DrugPancreatic ductal adenocarcinomaKey genesbusiness.industrymedia_common.quotation_subjectPancreatic ductal adenocarcinoma gemcitabine indole derivatives anti-proliferative activity antimigratory activity SF3B1 RON hENT1Affect (psychology)medicine.diseaseGemcitabineMetastasisPancreatic cancerCancer researchmedicinebusinessmedia_commonmedicine.drugCancer drug resistance (Alhambra, Calif.)
researchProduct

Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas

2021

Abstract Background Oncogenic Kras initiates and drives carcinogenesis in the pancreas by complex signaling networks, including activation of the NFκB pathway. Although recent evidence has shown that oncogenic gains in Nfκb2 collaborate with Kras in the carcinogenesis, no data at the level of genetics for the contribution of Nfκb2 is available so far. Methods We used Nfkb2 knock-out mice to decipher the role of the gene in Kras-driven carcinogenesis in vivo. Results We show that the Nfkb2 gene is needed for cancer initiation and progression in KrasG12D-driven models and this requirement of Nfkb2 is mechanistically connected to proliferative pathways. In contrast, Nfκb2 is dispensable in agg…

Endocrinology Diabetes and Metabolismmedicine.disease_causelaw.invention03 medical and health sciences0302 clinical medicinelawPancreatic cancermedicineGeneHepatologyOncogenebusiness.industryGastroenterologyCancermedicine.diseasedigestive system diseasesddc:medicine.anatomical_structure030220 oncology & carcinogenesisCancer researchSuppressor030211 gastroenterology & hepatologyKRASCarcinogenesisbusinessPancreas
researchProduct

Biliopancreatic Endoscopy in Altered Anatomy

2021

Background and Objectives: Anatomical post-surgical alterations of the upper gastrointestinal (GI) tract have always been challenging for performing diagnostic and therapeutic endoscopy, especially when biliopancreatic diseases are involved. Esophagectomy, gastrectomy with various reconstructions and pancreaticoduodenectomy are among the most common surgeries causing upper GI tract alterations. Technological improvements and new methods have increased the endoscopic success rate in these patients, and the literature has been rapidly increasing over the past few years. The aim of this systematic review is to identify evidence on the available biliopancreatic endoscopic techniques performed i…

Endoscopic ultrasoundMedicine (General)medicine.medical_treatmentCochrane LibraryEndosonographyERCPR5-920GastrectomyMedicinedifficult biliary stonesHumansProspective StudiesRetrospective StudiesCholangiopancreatography Endoscopic RetrogradeEndoscopic retrograde cholangiopancreatographyUSmedicine.diagnostic_testbusiness.industryinterventional EUSRetrospective cohort studyGeneral MedicineAnatomyPancreaticoduodenectomyEndoscopyEsophagectomyTherapeutic endoscopyFNBSystematic Reviewbusinessbiliopancreatic endoscopyCH-EUSMedicina
researchProduct

Endoscopic ultrasound and early diagnosis of pancreatic cancer

2007

Incidence of pancreatic cancer has increased, but prognosis remains poor. Curative treatment is dependent on early diagnosis. Endoscopic ultrasound (EUS) has been described as highly sensitive and accurate in staging, superior to other imaging modalities in early publications. With rapid advances in technology, other imaging techniques have reached better results. EUS still has the highest accuracy in assessing tumor size and lymph node involvement. For assessment of tumor respectability, a combination of a computed tomography (CT) scan and EUS seems to be the procedure with the highest accuracy. Promising new techniques might improve the diagnostic yield of EUS. But there are several reaso…

Endoscopic ultrasoundeducation.field_of_studymedicine.medical_specialtyPancreatic diseasemedicine.diagnostic_testTumor sizebusiness.industryPopulationUltrasoundGeneral Medicinemedicine.diseasedigestive system diseasesEndoscopymedicine.anatomical_structurePancreatic cancermedicineSurgeryRadiologyeducationbusinessLymph nodeThe American Journal of Surgery
researchProduct

Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐anal…

2020

Objectives Endoscopic ultrasound through-the-needle biopsy (EUS-TTNB) is a useful tool for differential diagnosis among pancreatic cystic lesions (PCLs). Cystic fluid cytology (CFC) is recommended by guidelines, but its diagnostic accuracy is about 50%. The aim of this meta-analysis is to assess the clinical impact of EUS-TTNB in terms of technical success (TS), histological accuracy (HA) and diagnostic yield (DY). Methods Original studies in English language on EUS-TTNB were searched in MEDLINE and EMBASE until October 2019. Diagnostic accuracy of EUS-TTNB for identification of mucinous PCLs was calculated using individual diagnostic data of patients who underwent CFC and surgery. Results …

Endoscopic ultrasoundmedicine.medical_specialtyserous cystadenomaEndosonographyhistologyCystic lesion03 medical and health sciences0302 clinical medicineBiopsymedicineHumansRadiology Nuclear Medicine and imagingCystAdverse effectEndoscopic Ultrasound-Guided Fine Needle AspirationPancreasIntraductal papillary mucinous neoplasmmedicine.diagnostic_testbusiness.industryIPMNintraductal papillary mucinous neoplasmGastroenterologymedicine.diseasedigestive system diseasesConfidence intervalPancreatic NeoplasmsFNA030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologyRadiologyPancreatic CystDifferential diagnosisbusinessDigestive Endoscopy
researchProduct

Extensive molecular analysis of patients bearing CFTR-related disorders.

2012

Cystic fibrosis transmembrane conductance regulator (CFTR)–related disorders (CFTR-RDs) may present with pancreatic sufficiency, normal sweat test results, and better outcome. The detection rate of mutations is lower in CFTR-RD than in classic CF: mutations may be located in genes encoding proteins that interact with CFTR or support channel activity. We tested the whole CFTR coding regions in 99 CFTR-RD patients, looking for gene mutations in solute carrier (SLC) 26A and in epithelial Na channel (ENaC) in 33 patients who had unidentified mutations. CFTR analysis revealed 28 mutations, some of which are rare. Of these mutations, RT-PCR demonstrated that the novel 1525-1delG impairs exon 10 s…

Epithelial sodium channelcongenital hereditary and neonatal diseases and abnormalitiesCystic fibrosis CFTR SLC26A SCNNCystic FibrosisAnion Transport ProteinsDNA Mutational Analysismolecular analysiCystic Fibrosis Transmembrane Conductance RegulatorGene mutationPathology and Forensic Medicinecongenital bilateral absence of vasa deferentesExonGene Frequencydisseminated bronchiectasiscongenital bilateral absence of vasa deferenteHumansTrypsinmolecular analysisEpithelial Sodium ChannelsGeneCells CulturedGenetic Association StudiesGeneticsbiologydisseminated bronchiectasiEpithelial Cellsrespiratory systemrecurrent pancreatitidigestive system diseasesCystic fibrosis transmembrane conductance regulatorrespiratory tract diseasesSolute carrier familyCFTR related disordersTrypsin Inhibitor Kazal PancreaticCase-Control StudiesRNA splicingMutationbiology.proteinMolecular MedicineCFTR related disorderSLC26 familyCarrier ProteinsNa channel ENaCMinigenerecurrent pancreatitis
researchProduct

Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.

2003

Psoriasis is a chronic inflammatory skin disease. Its treatment is based on the inhibition of proliferation of epidermal cells and interference in the inflammatory process. A new systemic antipsoriasis drug, which consists of dimethylfumarate and ethylhydrogenfumarate in the form of their calcium, magnesium and zinc salts has been introduced in Europe with successful results. In the present study, a homologous series of mono- and diesters of fumaric acid has been studied with respect to the sites and kinetics of presystemic ester degradation using pancreas extract, intestinal perfusate, intestinal homogenate and liver S9 fraction. In addition, intestinal permeability has been determined usi…

Fumaric acidCell Membrane PermeabilitySwineDimethyl FumaratePharmaceutical ScienceBiological AvailabilityPancreatic ExtractsIntestinal absorptionchemistry.chemical_compoundIntestinal mucosaFumaratesmedicineAnimalsHumansPsoriasisPharmacology (medical)Enzyme InhibitorsIntestinal MucosaCells CulturedPharmacologyIntestinal permeabilityDimethyl fumarateMicrovilliGeneral MedicineMetabolismmedicine.diseasePropranololIntestineschemistryBiochemistryS9 fractionAtenololIntestinal AbsorptionLipophilicityCaco-2 CellsLiver ExtractsBiopharmaceuticsdrug disposition
researchProduct

Proliferation of gastrointestinal carcinoma cells by T lymphocyte factors interleukin-3 and granulocyte-macrophage colony-stimulating factor

1991

Hematopoietic growth factors have been well characterized by cDNA cloning in recent years. In order to determine the influence of rhGM-CSF and rhIL-3 on epithelial cells of the gastrointestinal tract, their influence on in vitro cultured gastric and pancreas cancer cells was determined. A more than two-fold enhancement of proliferation was observed by IL-3 and GM-CSF in Mz-Sto-1 gastric and 818-4 pancreas carcinoma cells, applying a sensitive microculture system which allows precise quantification. The highest growth rates were obtained adding 1-10 ng/ml of the growth factors, but even picogram amounts were effective. Expression of mRNA for GM-CSF and IL-3 remained undetectable in the cell …

Gastrointestinal tractT-LymphocytesImmunologyGranulocyte-Macrophage Colony-Stimulating FactorBiologyLymphocyte ActivationMolecular biologyIn vitroPancreatic NeoplasmsHaematopoiesisGranulocyte macrophage colony-stimulating factorStomach NeoplasmsCell cultureCancer cellTumor Cells CulturedmedicineHumansInterleukin-3ReceptorCell DivisionInterleukin 3medicine.drugImmunologic Research
researchProduct